Medtronic has launched Multi-Lead Trialing Cable for use in the patient screening test for Medtronic spinal cord stimulation (SCS) therapy following the US Food and Drug Administration (FDA) clearance.
Introduced in the US, Europe and Canada, the streamlined trialing system allows physicians to test a wide array of stimulation settings prior to implanting a neurostimulator to provide long-term pain management.
The Multi-Lead Trialing Cable offers patients a comfortable trial experience and multiple secure lead configurations with up to 16 test electrodes and only one small cable and no extensions.
Medtronic Neuromodulation business senior vice president and president Tom Tefft said that one of many great benefits of spinal cord stimulation for the treatment of chronic, intractable pain is the ability for patients to test the therapy before receiving an implantable system.